Comparative Evaluation of Cell Proliferative Indices and Epidermal Growth Factor Receptor Expression in Gastric Carcinoma

Indian Journal of Pathology and Microbiology

Volumn 40, Issue 4, 1997, Pages 481-490

  Prakash, Ira ^a   Mathur, R P ^b   Kar, P ^b   Ranga, Sunil ^a   Talib, V H ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Epidermal growth factor receptor; Gastric carcinoma; Ki 67 labelling index; Nucleolar organizer region counts; Prognostic factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CHROMOSOME NOR; COMPARATIVE STUDY; HUMAN; METASTASIS; MITOSIS INDEX; PATHOLOGY; PROGNOSIS; STOMACH DISEASE; STOMACH TUMOR; ULTRASTRUCTURE;

HUMANS; KI-67 ANTIGEN; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH DISEASES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031241976     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stoschek CM, King LE : Role of epidermal growth factor in carcinogenesis. Cancer Res 46 : 1030-1033, 1986.
2. Lemoine NR, Hughes CM, Barton CM et al: The epidermal growth factor receptor in pancreatic cancer. J Pathol 166 : 7-12, 1992.
3. Gerdes J, Li L, Schlueter C : Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 138 : 867-873, 1991.
4. Gerdes J, Duchrow M, Schlueter C : Molecular cloning of the human Ki67 gene (MKI-67). Anal Cell Pathol 4: 159-160, 1992.
5. Dervan DA, Gilmartin LG, Loftus BM and Carney DN : Breast carcinoma Kinetics. Argyrophilic organizer region counts correlate with Ki67 scores. Am J Clin Pathol 92 : 401-407, 1989.
6. Alberts B, Bray J, Lewis J et al : Molecular biology of the cell. New York and London : Garland 424-426, 1983.
7. Lewin B : Gene expression, Eukaryotic Chromosome 2nd Ed. New York, Willey J 875-878, 1980.
8. Under wood JCE, Giri DD : Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol 155 : 95-96, 1988.
9. Ploton D, Menager M, Jeannesson P et al : Improvement in the staining and visualization of argyrophilic proteins of NOR at optical level. Histochem J 18 : 5-14, 1986.
10. Crocker J, Boldy DAR, Egan MJ : How should we count AgNORs? Proposals for a standardized approach. J Pathol 158 : 185-188, 1989.
11. Yonemura Y, Ooyama S, Sugiyama et al : Growth fractions in gastric carcinomas determined with monoclonal antibody Ki67. Cancer 65 : 1130-1134, 1990.
12. Yasui W, Sumiyoshi H, Hata J et al : Expression of EGFR in human gastric and colonic carcinoma. Cancer Res 48 : 137-141, 1988.
13. Sugiyama K, Yonemura Y and Miyazaki I : Immunohistochemical study of EGF and EGFR in gastric carcinoma. Cancer 63 : 1557-1561, 1989.
14. Grabiec J and Owen DA : Carcinoma of the stomach in young persons. Cancer 56 : 388-396, 1985.
15. Morson and Dawson : Gastrointestinal Pathology. Blackwell Scientific Publications, Oxford 100-187, 1990.
16. Paymaster JC, Sanghvi LD and Gangadharan P : Cancer in the gastrointestinal tract in Western India-Epidemiological study Cancer 21 : 279-288, 1968.
17. Paymaster JC, Potdar GG, de Souza LJ and Gangadharan P : Cancer of the stomach. Ind J of Cancer 10 : 1-12, 1973.
18. Serlin O, Keehn RJ, Higgins GA Jr, Harrower HW and Mendeloff GL : Factors related to survival following resection for gastric carcinoma. Analysis of 903 cases. Cancer 40 : 1318-1329, 1977.
19. Pfeiffer A, Rothbauer E, Weibecke B et al : Increased epidermal growth factor receptors in gastric carcinomas. Gastroenterology 98 : 961-967, 1990.
20. Lee EY, Cibull ML, Strodel WE, Haley JV : Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med 118 : 235-239, 1994.
21. Hirono Y, Tsugawa K, Fushida S et al : Amplification of epidermal growth factor receptor gene and its relationship to Survival in human gastric cancer. Oncoloogy 52 : 182-188, 1995.
22. Rodeck U, Herlyn M, Herlyn D et al : Tumour growth modulation by a monoclonal antibody to the EGF-receptor : Immunologically mediated and effector cell independent effect. Cancer Res 47 : 3692-3696, 1987.
23. Me Loughlin GA, Cave Bigley DJ, Tagore V, Kirkham N : Cyclophosphamide and pure squamous cell carcinoma of the stomach. Br Med JI : 524-525, 1980.
24. Kubota Y, Petras RE, Easley KA et al : Ki67 determined growth fraction versus standard staging and grading parameters in colorectal carcinoma : A multivariate analysis. Cancer 70 : 2602-2609, 1992.
25. Suarez V, Newman J, Hiley C, Crocker J and Collins M : the value of NOR numbers in neoplastic and non-neoplastic epithelium of the stomach. Histopathology 14 : 61-66, 1989.
26. Griffiths AP, Butler CW, Roberts P et al : Silver stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinomas. J Pathol 159 : 121-127, 1989.
27. Arora HL, Arora N, Solanki RL : Argyrophilic nucleolar organizer regions in soft tissue tumours. Ind J Pathol Microbiol 39 : 257-263, 1996.
28. Toi M, Nakamura T, Mukaida H et al : Relationship between EGFR status and various prognostic factors in human breast cancer. Cancer 65 : 1960-1984, 1990.